https://doi.org/10.1016/j.apsb.2025.06.002

This new article publication from Acta Pharmaceutica Sinica B, discusses key challenges in targeted treatment of brain metastatic non-small cell lung cancer.

https://doi.org/10.1016/j.apsb.2025.05.038

This new article publication from Acta Pharmaceutica Sinica B, discusses oral vaccines for conquering cancers and warding off infectious diseases.

https://doi.org/10.1016/j.apsb.2025.06.008

This new article publication from Acta Pharmaceutica Sinica B, discusses filamenting temperature-sensitive mutant Z as a novel target for antibiotics development.

https://doi.org/10.1016/j.apsb.2025.06.005

This new article publication from Acta Pharmaceutica Sinica B, discusses how the protein arginine methyltransferase PRMT1 ameliorates cerebral ischemia–reperfusion injury by suppressing RIPK1-mediated necroptosis and apoptosis.

https://doi.org/10.1016/j.apsb.2025.05.031

This new article publication from Acta Pharmaceutica Sinica B, discusses how a novel C-3-substituted oleanolic acid benzyl amide derivative exhibits therapeutic potential against influenza A.

https://doi.org/10.1016/j.apsb.2025.05.025

This new article publication from Acta Pharmaceutica Sinica B, discusses the efficacy of targeting the Keap1 system through the homoPROTAC-ing technology as an innovative and promising treatment strategy for the incurable allergic disorders.